“Cannabigerol (CBG) is one of the major phytocannabinoids present in Cannabis sativa L. that is attracting pharmacological interest because it is non-psychotropic and is abundant in some industrial hemp varieties.
The aim of this work was to investigate in parallel the binding properties of CBG to cannabinoid CB1 (CB1R) and CB2 (CB2R) receptors and the effects of the compound on agonist activation of those receptors and of CB1-CB2 heteroreceptor complexes.
The results indicate that CBG is indeed effective as regulator of endocannabinoid signaling.”
https://www.ncbi.nlm.nih.gov/pubmed/29977202
https://www.frontiersin.org/articles/10.3389/fphar.2018.00632/full